Abstract
Everolimus Plus Itacitinib in Relapsed/Refractory Classical Hodgkin Lymphoma: Results of a Phase I/II Investigator Initiated Trial (EVITA Study)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have